Immunization trials with the ring-infected erythrocyte surface antigen of Plasmodium falciparum in owl monkeys (Aotus vociferans). 1988

W E Collins, and M Pappaioanou, and R F Anders, and G H Campbell, and G V Brown, and D J Kemp, and J R Broderson, and R L Coppel, and J C Skinner, and P M Procell
Division of Parasitic Diseases, Center for Infectious Diseases, Atlanta, Georgia 30333.

A protocol was developed for the testing of blood stage vaccines against Plasmodium falciparum using Peruvian Aotus vociferans and the Indochina I/CDC strain of the parasite. Three different fused polypeptide vaccines containing elements of the ring-infected erythrocyte surface antigen molecule combined with Freund's complete and Freund's incomplete adjuvants were tested to determine their ability to protect against overwhelming infection following challenge with this highly virulent strain of P. falciparum, and to invoke antibody responses as measured by a standard indirect immunofluorescence technique. Nine of 14 immunized animals exhibited some protection. Presented are the test procedures developed for the conduct of such trials with New World monkeys and the analysis of results that led to the identification of variables selected for study in future trials.

UI MeSH Term Description Entries
D007114 Immunization Deliberate stimulation of the host's immune response. ACTIVE IMMUNIZATION involves administration of ANTIGENS or IMMUNOLOGIC ADJUVANTS. PASSIVE IMMUNIZATION involves administration of IMMUNE SERA or LYMPHOCYTES or their extracts (e.g., transfer factor, immune RNA) or transplantation of immunocompetent cell producing tissue (thymus or bone marrow). Immunologic Stimulation,Immunostimulation,Sensitization, Immunologic,Variolation,Immunologic Sensitization,Immunological Stimulation,Sensitization, Immunological,Stimulation, Immunologic,Immunizations,Immunological Sensitization,Immunological Sensitizations,Immunological Stimulations,Sensitizations, Immunological,Stimulation, Immunological,Stimulations, Immunological,Variolations
D008288 Malaria A protozoan disease caused in humans by four species of the PLASMODIUM genus: PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM OVALE; and PLASMODIUM MALARIAE; and transmitted by the bite of an infected female mosquito of the genus ANOPHELES. Malaria is endemic in parts of Asia, Africa, Central and South America, Oceania, and certain Caribbean islands. It is characterized by extreme exhaustion associated with paroxysms of high FEVER; SWEATING; shaking CHILLS; and ANEMIA. Malaria in ANIMALS is caused by other species of plasmodia. Marsh Fever,Plasmodium Infections,Remittent Fever,Infections, Plasmodium,Paludism,Fever, Marsh,Fever, Remittent,Infection, Plasmodium,Plasmodium Infection
D010963 Plasmodium falciparum A species of protozoa that is the causal agent of falciparum malaria (MALARIA, FALCIPARUM). It is most prevalent in the tropics and subtropics. Plasmodium falciparums,falciparums, Plasmodium
D005620 Freund's Adjuvant An antigen solution emulsified in mineral oil. The complete form is made up of killed, dried mycobacteria, usually M. tuberculosis, suspended in the oil phase. It is effective in stimulating cell-mediated immunity (IMMUNITY, CELLULAR) and potentiates the production of certain IMMUNOGLOBULINS in some animals. The incomplete form does not contain mycobacteria. Freund Adjuvant,Adjuvant, Freund,Adjuvant, Freund's,Freunds Adjuvant
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000913 Antibodies, Protozoan Immunoglobulins produced in a response to PROTOZOAN ANTIGENS. Protozoan Antibodies
D000953 Antigens, Protozoan Any part or derivative of any protozoan that elicits immunity; malaria (Plasmodium) and trypanosome antigens are presently the most frequently encountered. Protozoan Antigens
D000954 Antigens, Surface Antigens on surfaces of cells, including infectious or foreign cells or viruses. They are usually protein-containing groups on cell membranes or walls and may be isolated. Cell Surface Antigens,Surface Antigens,Surface Markers, Immunological,Cell Surface Antigen,Immunologic Surface Markers,Markers, Immunological Surface,Surface Antigen,Surface Markers, Immunologic,Antigen, Cell Surface,Antigen, Surface,Antigens, Cell Surface,Immunological Surface Markers,Markers, Immunologic Surface,Surface Antigen, Cell,Surface Antigens, Cell
D001029 Aotus trivirgatus A species in the family AOTIDAE, inhabiting the forested regions of Central and South America (from Panama to the Amazon). Vocalizations occur primarily at night when they are active, thus they are also known as Northern night monkeys. Humboldt's Night Monkey,Monkey, Northern Night,Night Monkey, Northern,Humboldt Night Monkey,Humboldts Night Monkey,Monkey, Humboldt's Night,Night Monkey, Humboldt's,Northern Night Monkey,Northern Night Monkeys
D014612 Vaccines Suspensions of killed or attenuated microorganisms (bacteria, viruses, fungi, protozoa), antigenic proteins, synthetic constructs, or other bio-molecular derivatives, administered for the prevention, amelioration, or treatment of infectious and other diseases. Vaccine

Related Publications

W E Collins, and M Pappaioanou, and R F Anders, and G H Campbell, and G V Brown, and D J Kemp, and J R Broderson, and R L Coppel, and J C Skinner, and P M Procell
January 1991, The American journal of tropical medicine and hygiene,
W E Collins, and M Pappaioanou, and R F Anders, and G H Campbell, and G V Brown, and D J Kemp, and J R Broderson, and R L Coppel, and J C Skinner, and P M Procell
August 1991, The Journal of parasitology,
W E Collins, and M Pappaioanou, and R F Anders, and G H Campbell, and G V Brown, and D J Kemp, and J R Broderson, and R L Coppel, and J C Skinner, and P M Procell
January 1992, Memorias do Instituto Oswaldo Cruz,
W E Collins, and M Pappaioanou, and R F Anders, and G H Campbell, and G V Brown, and D J Kemp, and J R Broderson, and R L Coppel, and J C Skinner, and P M Procell
June 1970, Zeitschrift fur Tropenmedizin und Parasitologie,
W E Collins, and M Pappaioanou, and R F Anders, and G H Campbell, and G V Brown, and D J Kemp, and J R Broderson, and R L Coppel, and J C Skinner, and P M Procell
July 1969, The Journal of tropical medicine and hygiene,
W E Collins, and M Pappaioanou, and R F Anders, and G H Campbell, and G V Brown, and D J Kemp, and J R Broderson, and R L Coppel, and J C Skinner, and P M Procell
January 1990, Journal of medical primatology,
W E Collins, and M Pappaioanou, and R F Anders, and G H Campbell, and G V Brown, and D J Kemp, and J R Broderson, and R L Coppel, and J C Skinner, and P M Procell
May 1991, Molecular and biochemical parasitology,
W E Collins, and M Pappaioanou, and R F Anders, and G H Campbell, and G V Brown, and D J Kemp, and J R Broderson, and R L Coppel, and J C Skinner, and P M Procell
December 1995, The American journal of tropical medicine and hygiene,
W E Collins, and M Pappaioanou, and R F Anders, and G H Campbell, and G V Brown, and D J Kemp, and J R Broderson, and R L Coppel, and J C Skinner, and P M Procell
August 2015, Journal of medical primatology,
W E Collins, and M Pappaioanou, and R F Anders, and G H Campbell, and G V Brown, and D J Kemp, and J R Broderson, and R L Coppel, and J C Skinner, and P M Procell
August 1985, The Journal of experimental medicine,
Copied contents to your clipboard!